基本信息:
- 专利标题： PYRAZOLE COMPOUNDS
- 专利标题（中）：吡唑化合物
- 申请号：PCT/US2012/056999 申请日：2012-09-25
- 公开(公告)号：WO2013048989A2 公开(公告)日：2013-04-04
- 发明人： SHIA, Kak-Shan , CHANG, Chun-Ping , CHAO, Yu-Sheng
- 申请人： NATIONAL HEALTH RESEARCH INSTITUTES , SHIA, Kak-Shan , CHANG, Chun-Ping , CHAO, Yu-Sheng
- 申请人地址： No. 35, Keyan Road Zhunan Town Miaoli County, 350 TW
- 专利权人： NATIONAL HEALTH RESEARCH INSTITUTES,SHIA, Kak-Shan,CHANG, Chun-Ping,CHAO, Yu-Sheng
- 当前专利权人： NATIONAL HEALTH RESEARCH INSTITUTES,SHIA, Kak-Shan,CHANG, Chun-Ping,CHAO, Yu-Sheng
- 当前专利权人地址： No. 35, Keyan Road Zhunan Town Miaoli County, 350 TW
- 代理机构： TSAO, Y. Rocky
- 优先权： US61/541,182 20110930
摘要：
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the Specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
摘要（中）：
公开了由说明书中所示的式（I）包含的吡唑化合物，其可用于治疗外周大麻素1受体介导的病症。 还公开了与使用这些化合物有关的药物组合物和方法。